Wednesday, September 3, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Dr Biola M. Javierre receives a prestigious grant for the study of B-cell Lymphoma

June 14, 2024
in Cancer
Reading Time: 3 mins read
0
Dr Biola M. Javierre, Group Leader at the Josep Carreras Leukaemia Research Institute
65
SHARES
592
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Today, the European Haematology Association (EHA) has awarded its prestigious and exclusive Bilateral Collaborative Grants in Madrid, as part of the opening ceremony of the EHA Annual Congress. Among the selected projects is the one proposed by Dr Biola M. Javierre, head of the 3D chromatin organisation research group at the Josep Carreras Leukaemia Research Institute, and Dr Björn Chapuy from Charité Universitätsmedizin Berlin (Germany). The project aims to shed light on the role of mutations in noncoding regions of the genome in the development of diffuse large B-cell lymphoma (DLBCL).

Dr Biola M. Javierre, Group Leader at the Josep Carreras Leukaemia Research Institute

Credit: Josep Carreras Leukaemia Research Institute

Today, the European Haematology Association (EHA) has awarded its prestigious and exclusive Bilateral Collaborative Grants in Madrid, as part of the opening ceremony of the EHA Annual Congress. Among the selected projects is the one proposed by Dr Biola M. Javierre, head of the 3D chromatin organisation research group at the Josep Carreras Leukaemia Research Institute, and Dr Björn Chapuy from Charité Universitätsmedizin Berlin (Germany). The project aims to shed light on the role of mutations in noncoding regions of the genome in the development of diffuse large B-cell lymphoma (DLBCL).

To qualify for the Bilateral Collaborative Grants, projects must meet very stringent criteria, such as coming from two independent research groups based in Europe with shared interests and complementary expertise. This collaboration is expected to enrich both groups and generate high-impact new knowledge.

The EHA is the largest association of haematologists in Europe, dedicated to promoting excellence in patient care, research, and education. Its annual congress gathers thousands of specialists to discuss the latest developments in the field and serves as an ideal platform to establish new collaborations.

This current research proposal emerged from such collaborative environments. Dr Javierre will provide her expertise in the liCHi-C promoter capture method, developed in her laboratory, in collaboration with Dr Björn Chapuy, who has an extensive catalogue of DLBCL samples and preclinical models. The project will be funded for two years of high-level research and will include the recruitment of new researchers.

Mutations in noncoding regions

In recent years, up to five subtypes of DLBCL have been identified, each characterised by specific genetic alterations (mutations). This facilitates diagnosis and provides clues about the disease’s progression, which is crucial for clinical management. However, many lymphomas still do not have a known cause, making ongoing research essential to find answers.

Previous studies of the DLBCL tumour genome have shown that many mutations, although not directly affecting genes, impact the disease’s development. Many of these mutations occur in distant regulatory regions, parts of the genome that control the function of genes located at considerable distances.

The challenge is that, generally, it is not known which genes are controlled by each of these regions. They could be many, and not all related to DLBCL. Therefore, Dr Javierre’s team will use the liCHi-C methodology, capable of determining which genes physically contact these regulatory regions and are thus under their influence.

Although the experimental work will be conducted in preclinical models of the disease and is not expected to have an immediate impact on patients, this research will identify which genes are affected by mutations in noncoding regions and their role in the development of DLBCL. It is hoped that this information can be used to benefit patients, either as disease biomarkers or as new therapeutic targets in the future.



Share26Tweet16
Previous Post

New and crucial role discovered for a protein in the body’s immunity against cancer

Next Post

Fasting primes the immune system’s natural killer cells to better fight cancer, new study in mice finds

Related Posts

blank
Cancer

Revolutionary Framework Enhances Liver Imaging Segmentation

September 2, 2025
blank
Cancer

Drug Targeting Mitochondria Strikes Cancer Cells from Within

September 2, 2025
blank
Cancer

New Variant of Mesothelioma Discovered: Insights from Two Studies in the Journal of Thoracic Oncology

September 2, 2025
blank
Cancer

Shorter, Milder Radiation-Chemo Effective for HPV-Linked Oropharyngeal Cancer, Mayo Study Finds

September 2, 2025
blank
Cancer

How Nanoparticles Are Revolutionizing Therapeutic Vaccines for HPV-Related Tumors

September 2, 2025
blank
Cancer

Breakthrough Genetic Biomarker Identifies Aggressive Brain Tumors

September 2, 2025
Next Post
Drs. Rebecca Delconte and Joseph Sun

Fasting primes the immune system’s natural killer cells to better fight cancer, new study in mice finds

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27543 shares
    Share 11014 Tweet 6884
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    957 shares
    Share 383 Tweet 239
  • Bee body mass, pathogens and local climate influence heat tolerance

    643 shares
    Share 257 Tweet 161
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    510 shares
    Share 204 Tweet 128
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    313 shares
    Share 125 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Coastal Stressors Impact Crop Yields and Soil Nutrients
  • Transposable Elements Influence Geese’s Fat and Egg Traits
  • Honey Bee Antimicrobial Peptides Combat SARS-CoV-2
  • Trans transcriptome Assembly and Gene Expression Analysis

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,183 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading